Back to search
FDAFDA · Food and drugs·Recall number D-1386-2014

Vancomycin Hydrochloride Capsules, USP, 250 mg. 20 Capsules on 2 x 10 Capsule Blister Cards, Rx Only. Mfd. for: Watson Pharma Inc., Parsippany, NJ 07054 USA. Mfd. by: Patheon Pharmaceuticals Inc., Cincinnati, OH 45237 USA. NDC 0591-3561-15.

Published June 25, 2014 · Recall initiated: May 16, 2014

Summary

FDA records drug Class II recall D-1386-2014, published June 25, 2014 and initiated May 16, 2014. Recalling firm: Actavis Inc; Status: Terminated; Reported quantity: 6913 packages; Lot: Lot #: 3100135, Expiry: 05/2014. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Actavis Inc
Distributor
U.S. Nationwide
Lot
Lot #: 3100135, Expiry: 05/2014
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Vancomycin Hydrochloride Capsules, USP, 250 mg. 20 Capsules on 2 x 10 Capsule Blister Cards, Rx Only. Mfd. for: Watson Pharma Inc., Parsippany, NJ 07054 USA. Mfd. by: Patheon Pharmaceuticals Inc., Cincinnati, OH 45237 USA. NDC 0591-3561-15. recalled?

Yes. FDA published recall D-1386-2014 on June 25, 2014. Reported hazard: Subpotent Drug.

What should I do if I have this product?

Voluntary: Firm initiated · Letter